Stratasys Expands Availability of RadioMatrix Radiopaque Material in the US.
ByAinvest
Monday, Dec 1, 2025 8:18 am ET1min read
SSYS--
Stratasys has expanded the availability of its RadioMatrix radiopaque material in the US, allowing healthcare providers, device manufacturers, and research institutions to access and utilize the material for advanced medical imaging and training applications. The material enables precise control of radiopacity and can produce patient-specific models with repeatable, consistent, and fully tunable visibility on X-ray-based imaging. It has been validated by Siemens Healthineers and is expected to improve how radiologists validate and optimize CT protocols and accelerate the development of new imaging algorithms.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet